Document is current
Any future updates will be listed below
-
Authors
Croucher, Nicholas J. https://orcid.org/0000-0001-6303-8768
Campo, Joseph J. https://orcid.org/0000-0002-8652-0917
Le, Timothy Q.
Pablo, Jozelyn V.
Hung, Christopher
Teng, Andy A.
Turner, Claudia
Nosten, François https://orcid.org/0000-0002-7951-0745
Bentley, Stephen D. https://orcid.org/0000-0001-8094-3751
Liang, Xiaowu
Turner, Paul https://orcid.org/0000-0002-1013-7815
Goldblatt, David https://orcid.org/0000-0002-0769-5242
-
Funding
Funding for this research was provided by:
Wellcome Trust (104169/Z/14/A, 206194, 083735/Z/07/Z)
RCUK | Medical Research Council (MR/R015600/1)
Bill and Melinda Gates Foundation
Bill and Melinda Gates Foundation
Bill and Melinda Gates Foundation
Bill and Melinda Gates Foundation
Bill and Melinda Gates Foundation
Bill and Melinda Gates Foundation
- License Information
-
More Information
Article History
Received: 3 August 2023
Accepted: 19 December 2023
First Online: 8 January 2024
Competing interests
: J.J.C., T.Q.L., J.V.P., C.H., A.A.T. and X.L. are employees of Antigen Discovery, Inc. X.L. has an equity interest in Antigen Discovery, Inc. N.J.C. has consulted for Antigen Discovery Inc. and Pfizer, has been invited to attend meetings organised by Merck, and has received an investigator-initiated award from GlaxoSmithKline. S.D.B. has consulted for Pfizer and Merck. The remaining authors declare no competing interests.
